epilepsy News & Analysis

NeuroPace (NPCE) Receives FDA Approval for ECoG Assistant™

NeuroPace, Inc. (NPCE) announced on May 29 that it received FDA approval for its ECoG Assistant, an AI-driven feature designed to enhance epilepsy care using long-term intracranial EEG data. The tool is built on 124,450 epileptologist-labeled records, providing physicians with insights through integrated reports and charts. This approval represents a significant step towards practical tools for clinicians according to CEO Joel Becker. The company is also targeting FDA approval for its next-generation patient data platform in the second quarter of 2026.